Wessex NHS: Pre-notice of a tender for a Managed Service Contract (MSC) for Molecular Diagnostics and future sub-categories of Microbiology

UK-Southampton: Pathology services.


Preliminary Questions
   This notice is for prior information only: Yes
   This notice aims at reducing time-limits for receipt of tenders: No
   This notice is a call for competition: No
         
Section I: Contracting Authority

I.1) Name and addresses:
       Wessex NHS Procurement Limited, 11986173
       Tremona Road, Southampton, SO16 6YD, United Kingdom
       Tel. +44 7799316082, Email: Deborah.parin@wpl.uhs.nhs.uk
       Contact: Deborah Parin Steve Jerrim
       Main Address: https://www.hampshirehospitals.nhs.uk/, Address of the buyer profile: https://www.hampshirehospitals.nhs.uk/
       NUTS Code: UKJ
      Specifications and additional documents: As Above
I.2) Joint procurement:
   The contract involves joint procurement: Yes.
   In the case of joint procurement involving different countries, state applicable national procurement law:       Not Provided
   The contract is awarded by a central purchasing body: Yes .

I.3) Communication          
   Further information can be obtained from: the above mentioned address

I.4) Type of the contracting authority    
   Body governed by public law
I.5) Main activity:    
   Health

Section II: Object
      
II.1) Scope of the procurement - 1
   II.1.1) Title: Pre-notice of a tender for a Managed Service Contract (MSC) for Molecular Diagnostics and future sub-categories of Microbiology    
          Reference number: WPL01657
   II.1.2) Common Procurement Vocabulary:       
      85111800 - Pathology services.
   II.1.3) Type of contract: SERVICES
   II.1.4) Short description:    
      This Notice is to inform potential bidders that Wessex NHS Procurement Limited (WPL) will be advertising a tender opportunity in June 2022 for the provision of a Managed Service Contract (MSC) for Molecular Diagnostics on behalf of the Southern Counties Pathology Network (SCP). WPL will require potential bidders to have the capability and capacity to undertake compliant procurement responsibility for both mini competitions and tenders that adhere to Public Contracts Regulations 2015 (PCR 2015) (and/or the latest Procurement legislation applicable throughout the duration of the contract). These to include future sub-categories of Microbiology as managed service contracts, to be included within the main managed service contract, on behalf of SCP.          
   II.1.5) Estimated total value:       
      Value excluding VAT (give figures only) : 118,000,000 - GBP
   II.1.6) Information about lots:
      This contract is divided into lots: No          
      Maximum number of lots that may be awarded to one tenderer: Not Provided       
      The contracting authority reserves the right to award contracts combining the following lots or groups of lots: Not Provided

II.2) Lot Description    
   II.2.3) Place of performance:       
      Region Codes:               
         UKJ - SOUTH EAST (ENGLAND)    
   II.2.4) Description of the procurement:       
      Southern Counties Pathology (SCP) is a procurement consortium of NHS and Foundation Trusts that forms the NHS Improvement South 6 Pathology Network: SCP consists of:
Isle of Wight NHS Trust
Hampshire Hospitals NHS Foundation Trust
Dorset County Hospital NHS Foundation Trust and University Hospitals Dorset NHS Foundation Trust comprise One Dorset Pathology
Portsmouth Hospitals University NHS Trust
Salisbury NHS Foundation Trust
University Hospitals Southampton NHS Foundation Trust (Not participating in this tender)
SCP is a procurement collaboration which aims to deliver the procurement objectives of the South 6 Pathology Network which are:
To enable the future formation of a consolidated pathology network over the next ten years by standardising our suppliers and the equipment they supply to us, to deliver our high-volume routine pathology activity and to achieve cost savings by reducing non-pay spend on our high-volume routine pathology activity. There has been expansion of molecular techniques within the diagnostic laboratory environment at all partner trusts within the SCP network in recent years. Drivers for change include:
Continual growth in the number of different molecular assays being performed
Clinical requirements for greater molecular testing
A need for improvement in turnaround times
Better management of the increasing number of different platforms, suppliers and contracts
A dramatic shift in the requirement for rapid and largescale testing of respiratory viruses

The primary goals considered when developing the scope of this requirement are:
Distribute molecular services based on clinical need and urgency
Where possible, rationalise non urgent work at fewer sites
Repatriate currently referred work into the SCP network where cost effective
Consider the design of future services where COVID testing regimes can be flexed to respond to UKHSA/Government directives
A regional molecular service which can respond rapidly
Access to the latest technology
Integration and interfacing to support the development of Pathology network operations
Respiratory virus testing including covid and development of the future service delivery model.
SCP will utilise the award of a new regional managed service contract (MSC) as an opportunity to support the development of regional respiratory virus testing. This will provide flexibility as further guidance and policy is defined
Contract value
The estimated value of this MSC for Molecular Diagnostics is £36,000,000. The estimated value of all sub-categories of Microbiology, including Molecular Diagnostics is £118,000,000. Any future contracts awarded will complete co-terminus with the overarching Pathology contract within the SCP network on 19th July 2031.
WPL is running the procurement for a managed service contract for molecular diagnostics on behalf of SCP. WPL is a newly formed joint venture subsidiary of University Hospital Southampton NHS Foundation Trust and Hampshire Hospitals NHS Foundation Trust
This PIN is to inform the market that a contract notice will be published during June 2022 providing further information regarding this opportunity. This Tender will be run as a Competitive Procedure with Negotiation however the contracting authority reserves the right to award a contract based on initial tenders without conducting negotiations. Potential bidders will be invited to complete a Selection Questionnaire (SQ) Stage 1 that will be evaluated and scored and only the top 3 scoring potential bidders will proceed to the Invitation to Tender (ITT) Stage 2. If a potential bidder has an equal score within the Top 3 then they also proceed to the ITT Stage 2. Potential bidders who fail to achieve a Top 3 score will not be invited to the ITT Stage 2 and will leave the procurement process at Stage 1. This PIN is for information only and we are unable to respond for further requests for information    
   II.2.14) Additional information          
      Additional sub-categories may include but is not limited to: Blood culture diagnostics, Procurement of culture media (conventional & chromogenic), Urine analysis (microscopy & culture), Antimicrobial susceptibility testing, Microbial identification systems, Automation for microbial culture Mycobacterial diagnosis. Further information will be provided in the Contract Notice    


II.3) Estimated Date of publication
         27/06/2022
      
      
Section IV: Procedure   

IV.1) Description       
   IV.1.8) Information about Government Procurement Agreement (GPA )
         The contract is covered by the Government Procurement Agreement (GPA) - YES

Section VI: Complementary Information    
VI.3) Additional Information:       
   To view this notice, please click here:
https://www.delta-esourcing.com/delta/viewNotice.html?noticeId=684732166
GO-2022517-PRO-20149200 TKR-2022517-PRO-20149199        

VI.5) Date Of Dispatch Of This Notice: 17/05/2022

   
ANNEX A    
   
   IV) Address of the other contracting authority on behalf of which the contracting authority is purchasing
      Purchased on behalf of other contracting authority details:          
      
      1: Contracting Authority
       Hampshire Hospitals NHS Foundation Trust (HHFT)
       Aldermaston Road, Basingstoke, RG24 9NA, United Kingdom
       Email: Deborah.parin@wpl.uhs.nhs.uk
       Contact: Debbie Parin
       Main Address: http://www.hampshirehospitals.nhs.uk/
       NUTS Code: UKJ          
      
      2: Contracting Authority
       Portsmouth Hospitals University Trust
       Southwick Hill Road, Cosham, Portsmouth, PO6 3LY, United Kingdom
       Email: Deborah.parin@wpl.uhs.nhs.uk
       Contact: Debbie Parin
       Main Address: https://www.porthosp.nhs.uk/
       NUTS Code: UKJ          
      
      3: Contracting Authority
       Salisbury NHS Foundation Trust
       Odstock Road, Salisbury, SP2 8BJ, United Kingdom
       Email: Deborah.parin@wpl.uhs.nhs.uk
       Contact: Debbie Parin
       Main Address: http://www.salisbury.nhs.uk/
       NUTS Code: UKJ          
      
      4: Contracting Authority
       Isle of Wight NHS Trust
       Parkhurst Road, Newport, PO30 5TG, United Kingdom
       Email: Deborah.parin@wpl.uhs.nhs.uk
       Contact: Debbie Parin
       Main Address: https://www.iow.nhs.uk/
       NUTS Code: UKJ          
      
      5: Contracting Authority
       University Hospitals Dorset NHS Foundation Trust
       Poole Hospital, Longfleet Road, Poole, BH15 2JB, United Kingdom
       Email: Deborah.parin@wpl.uhs.nhs.uk
       Contact: Debbie Parin
       Main Address: https://www.uhd.nhs.uk/
       NUTS Code: UKJ          
      
      6: Contracting Authority
       Dorset County Hospital NHS Foundation Trust
       Dorset County Hospital, Williams Avenue, Dorchester, DT1 2JY, United Kingdom
       Email: Deborah.parin@wpl.uhs.nhs.uk
       Contact: Debbie Parin
       Main Address: https://www.dchft.nhs.uk/
       NUTS Code: UKJ